Imris today reported that it saw sales grow 44% last year and has seen sales rise 68% this year after it was reorganized in a bankruptcy purchase 2 years ago. The Minnetonka, Minn.-based company said that in the past 2 years, it has inked multi-million dollar contracts with hospitals across the globe and has added and […]
Imris Inc.
Ex-Siemens Healthcare exec Sorensen gets in on Deerfield’s Imris buy
Dr. Gregory Sorensen, the former chief of Siemens Healthcare (NYSE:SI) North America division, is taking out a minority stake in Deerfield Imaging, the former Imris business the investment company bought out of bankruptcy this year. Imris and 2 subsidiaries, including its NeuroArm Surgical business, filed for Chapter 11 bankruptcy protection last May, under a bailout plan with Deerfield Management. […]
Imris files for Chapter 11 bankruptcy
Imris Inc. (TSX:IM) said today that it and 2 subsidiaries, including its NeuroArm Surgical business, filed for Chapter 11 bankruptcy protection.
Stryker, Imris ink deal for spinal imaging suites
Former Abbott exec takes the helm at Creganna-Tactx Medical | Personnel Moves
Creganna-Tactx Medical CEO Helen Ryan is preparing to pass the torch after 8 years in the corner office, with Abbott (NYSE:ABT) executive Robert "Chip" Hance slated to take the helm in September.
Online insurance marketplaces face challenges
MASSDEVICE ON CALL — New insurance marketplace exchanges are a major policy platform of the Affordable Care Act, but some experts fear technical difficulties as the deadline rapidly approaches this October, according to The Wall Street Journal.
The tech experts building the government exchange websites warned customer to expect glitches when the system first goes live, the newspaper said.
Medtronic: Defibrillator market is stabilizing | Wall Street Beat
Elekta’s Q3 sales spike, earnings soar | Earnings Roundup
Zoll shares spike 23 percent on record 2011 sales and earnings | Earnings Roundup
Zoll reported record numbers in its top and bottom line for fiscal year 2011, sending its stock up 23 percent overnight.
Zoll shares were trading at $44.35 in the early afternoon today, up from last night’s $35.98 close.
The company’s 2011 sales hit a record high of $523.7 million, 18 percent higher than the $444 million posted last year.
Varian, Imris to co-develop MR-guided cancer device
Varian Medical Systems Inc. (NYSE:VAR) and IMRIS Inc. (TSX:IM) inked a co-development deal to create a magnetic-resonance-guided radiation therapy system to treat cancer.
The deal calls for the integration of Winnipeg, Manitoba-based Imris’ MR imaging technology with Palo Alto, Calif.-based Varian’s TrueBeam radiosurgery device.
